Healthcare
KKR sells stake in Japan's Panasonic Healthcare to Mitsui
KKR has sold a 22% stake in Panasonic Healthcare, a Japanese medical equipment manufacturer in which it acquired a majority interest in 2014, to Mitsui & Co. for JPY54.1 billion ($510 million).
CDH, CCB exit Chinese hospital operator to Taiking Insurance
CDH Investments and CCB International have sold their stakes in Harmonicare Medical Holdings, operator of 11 women and children’s hospitals in China, to Taikang Insurance Group for HK$815.2 million ($105.1 million).
Hony emphasizes its global ambitions
Hony Capital has reiterated its commitment to helping Chinese companies go global, in addition to supporting international firms that want to maximize their exposure to China – and the firm established a presence in Shenzhen to address these opportunities.
Ascendent backs China cancer diagnostics firm
Ascendent Capital Partners has committed RMB50 million ($7.36 million) to BioChain Beijing, a Chinese biotech company that focuses on early detection of cancer.
China's Betta Pharma completes $106m domestic IPO
Betta Pharmaceuticals, a Chinese VC-backed drug developer backed by several venture investors, has completed a RMB720 million ($106 million) IPO on Shenzhen’s Growth Enterprise Market Board.
J-Star owned insurer makes bolt-on acquisition
J-Star will take control of Japanese insurance provider Hunel FEA through a bolt-on acquisition by existing portfolio company Nihon Hoken Service.
Deal focus: Eywa brings experienced edge to generics
Eight Roads Ventures India sees considerable strengths in Eywa to tackle the lucrative US generic pharmaceuticals market
Everstone pays $33m for Indian drug firm
The Everstone Group has bought a majority stake in Indian pharmaceutical developer Rubicon Research for INR2.2 billion ($32.9 million), providing an exit for Kotak Private Equity.
Bain-owned APMG sells Southeast Asia assets
Asia Pacific Medical Group (APMG), a medical platform owned by Bain Capital, has agreed to sell Singapore and Malaysia-based plastic surgery brand The Sloane Clinic to China Medical (International) Group (CMIG).
Temasek invests $250m in China healthcare venture
Singapore's Temasek Holdings has committed $250 million to hospital operator Columbia Pacific Management for a joint venture in China.
Chinese investors in $30m round for US genetic testing firm
Trustbridge Partners has led a $30 million Series B round for US-based genetic testing company Veritas Genetics.
China boutique investment bank CEC buys Siemer & Associates
Chinese boutique investment bank and advisory firm CEC Capital Group – formerly known as China eCapital – has agreed to buy US-based counterpart Siemer & Associates (S&A).
Fidelity funds join $30m round for Singapore's Eywa
Eight Roads Ventures India and US-based F-Prime Capital - both of which are controlled by Fidelity - have joined a $30 million investment in Singapore and India-based drug manufacturer Eywa Pharma.
Invascent invests $6m in Indian IVF clinic chain
Indian healthcare-focused GP Invascent Capital has committed $6.2 million to in-vitro fertilization (IVF) clinic chain Oasis Centre for Reproductive Medicine.
Singapore’s New Silkroutes launches private equity JV
Singapore-listed energy trading company New Silkroutes Group (NSG) has formed a joint venture with three parties to develop private equity funds targeting healthcare and infrastructure in emerging and developed Asia.
IFC commits $11m to Indonesian gas producer's IPO
The International Finance Corporation (IFC) has invested $11 million in Indonesia-based Aneka Gas Industri as part of the gas production company’s domestic IPO.
J-Star buys Japan aged care services provider
J-Star will take control of Japanese aged care provider Live Cross through a bolt-on acquisition by the firm’s existing portfolio company Kairos Tokyo.
Japan's INCJ invests $102.6m in domestic VC funds
Innovation Network Corporation of Japan (INCJ) has committed up to JPY10.4 billion ($102.6 million) to funds managed by domestic VC firms MedVenture Partners and Universal Materials Incubator.
OneVentures commits $6.1m to Australia's MCRI
Australian life sciences and technology-oriented venture capital firm OneVentures has committed A$8 million ($6.1 million) to Melbourne-based Murdoch Childrens Research Institute (MCRI).
PE roll-ups: Consolidation game
Quadrant Private Equity's foray into the fitness club space represents the latest in a string of roll-up investments pursued by middle market Australian GPs. This strategy is a proven winner but execution risk should not be underestimated
PE-backed Go-Jek acquires India home healthcare start-up
Go-Jek, an Indonesian mobile ride-hailing and delivery platform backed by several PE investors, has bought Bangalore-based online home healthcare services platform Pianta, its third acquisition in India.
Sino-US bio-pharma firm raises $55m Series C
MicuRx Pharmaceuticals, a Sino-US bio-pharmaceutical company, has raised a $55 million Series C round of funding led by Shanghai-based GP Healthcare Capital.
Wingate, Sandbar acquire Australia's Medical Channel
Wingate Private Equity and Sandbar Investments have acquired Australian digital media provider Medical Channel.
CVC buys majority stake in Japan's Hasegawa
CVC Capital Partners has bought a controlling stake in Japanese assisted living, nursery school and cleaning services provider Hasegawa Holdings.